Adverse events on the rise

October 2007
Pharmaceutical Representative;Oct2007, Vol. 37 Issue 10, p11
The article presents a study which examines the serious adverse effects of drugs conducted by researchers from the Institute for Safe Medication Practices and the Wake-Forest University School of Medicine in Winston-Salem, North Carolina. According to the study, the number of deaths due to side effects accounted by the Food and Drug Administration (FDA) for eight-year period has doubled. Between 1998 and 2005, about 467, 809 serious adverse events were reported.


Related Articles

  • Biclustering of Adverse Drug Events in the FDA's Spontaneous Reporting System. Harpaz, R.; Perez, H.; Chase, H. S.; Rabadan, R.; Hripcsak, G.; Friedman, C. // Clinical Pharmacology & Therapeutics;Feb2011, Vol. 89 Issue 2, p243 

    In this article, we present a new pharmacovigilance data mining technique based on the biclustering paradigm, which is designed to identify drug groups that share a common set of adverse events (AEs) in the spontaneous reporting system (SRS) of the US Food and Drug Administration (FDA). A...

  • Med errors result from risperidone/ropinirole confusion.  // Reactions Weekly;6/25/2011, Issue 1357, p2 

    The article reports that the U.S. Food & Drug Administration (FDA) Adverse Event Reporting System (AERS) and the Institute for Safe Medication Practices in June 2011 have received wrong medication errors resulting from confusion between the antipsychotic risperidone and the antiparkinsonian...

  • ISMP Adverse Drug Reactions. Shuster, Joel // Hospital Pharmacy;Apr2009, Vol. 44 Issue 4, p293 

    The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MEDWATCH program (800-FDA-1088). If you have reported an interesting, preventable ADR to...

  • Rise in serious ADRs reported to US FDA.  // Reactions Weekly;11/1/2008, Issue 1226, p3 

    This article highlights data from the Institute for Safe Medication Practices on serious adverse drug reactions (ADR) reported to the U.S. Food and Drug Administration (FDA) in the first quarter of 2008. The agency received a total of 20,745 new reports of serious ADR including 4,824 reports of...

  • FDA Revises Safety Reporting Requirements for Investigational New Drug and Bioavailability and Bioequivalence Studies.  // Venulex Legal Summaries;2009 Q4, Special section p1 

    The article describes the notable features of the final rule revising and explaining the safety reporting requirements for investigational new drug (IND) products in Code of Federal Regulations (CFR) Part 312 and for bioavailability and bioequivalence studies in humans in 21 CFR Part 320. One of...

  • Adverse Events Reporting: So Far, So Good. Goldman, Erik // Nutraceuticals World;Jul/Aug2010, Vol. 13 Issue 6, p30 

    The article focuses on the need of cautiousness for the performance of the Adverse Events Reporting System (AERS) for dietary supplements. It states that supplement industry must be cautious with the system as it is voluntary and is less known by physicians and consumers. Meanwhile, it says that...

  • Educating patients about FDA's MedWatch. Tanzi, Maria G. // Pharmacy Today;Mar2013, Vol. 19 Issue 3, p26 

    The article focuses on patients education on MeWatch Adverse Reporting Program of the U.S. Food and Drug Administration (FDA). It says that the program determines medical products safety hazard signals, and MedWatch reports regarding adverse events linked with use of FDA-regulated drugs can be...

  • What you need to know about adverse-event reporting. Brienza, Susan D. // Natural Foods Merchandiser;Sep2009, Vol. 30 Issue 9, p26 

    The article offers guidelines for reporting adverse-events (AEs) relative to dietary supplements. It states that the event must be filed at the U.S. Food and Drug Administration (FDA) within 15 days. It cites questions that are necessary for investigation including one seeking for the supplement...

  • Adverse events rise.  // Pharmaceutical Representative;Dec2008, Vol. 38 Issue 12, p9 

    The article reports on the increasing claims of adverse effects on Chantix and Heparin drugs. According to the Institute for Safe Medication Practices (ISMP), the smoking cessation drug Chantix received several reports regarding its adverse reactions which caused serious injuries to patients....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics